Kolexia
Tison Francois Neurologie
Tison Francois
Neurologie
Hôpital Haut-lévêque
Pessac, France
183 Activités
13 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Atrophie Atrophie multisystématisée Syndromes parkinsoniens Maladie d'Alzheimer Démence Dyskinésies Ataxie Prédisposition génétique à une maladie

Collaborateurs

Voir plus
Meissner Wassilios
Meissner Wassilios
Hôpital Pellegrin, Bordeaux, France
Rascol Olivier
Rascol Olivier
Labo Pharmacol Med Et Clinique, Toulouse, France
Foubert-Samier Alexandra
Foubert-Samier Alexandra
Hôpital Pellegrin, Bordeaux, France
Damier Philippe
Damier Philippe
Hôpital Laennec, Saint-Herblain, France

Industries

Voir plus
Abbvie
1 collaboration(s)
Dernière en 2017
Pharma Dom
1 collaboration(s)
Dernière en 2017
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries.
Movement disorders : official journal of the Movement Disorder Society   29 février 2024
Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.
EBioMedicine   26 décembre 2023
Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL): Comparison of Therapeutic Strategies With Cholinesterase Inhibitors: Stop or Still (SOS) Trial
Essai Clinique (CHU Bordeaux)   05 octobre 2023
Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy.
Movement disorders clinical practice   17 juillet 2023
MAdaPARK: A Pilot Feasibility Study of a Co-constructed Program (Patients - Experts) of Mindfulness Meditation Adapted to Patients With Parkinson's Disease.
Essai Clinique (CHU Bordeaux)   20 janvier 2023
BIOPARK: Development of Biomarkers for the Diagnosis and Prognosis of Parkinsonian Syndromes Running Head: Biomarkers in Parkinsonian Syndromes
Essai Clinique (CHU Bordeaux)   30 mars 2022
M-PARK: Exploratory Feasibility Study for the Development of Mindfulness-based Stress Reduction Program (MBSR )in Parkinsonian Patients - MPARK
Essai Clinique (CHU Bordeaux)   05 janvier 2022
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial.
Journal of Parkinson's disease   15 septembre 2021
Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
Journal of neural transmission (Vienna, Austria : 1996)   16 juin 2021
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
Movement disorders : official journal of the Movement Disorder Society   01 avril 2021